The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Apr 2021)
Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
Laurence Booth,
Cameron West,
Daniel Von Hoff,
Paul Dent
Affiliations
Laurence Booth
Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, United States
Cameron West
Genzada Pharmaceuticals, Sterling, KS, United States
Daniel Von Hoff
Translational Genomics Research Institute (TGEN), Phoenix, AZ, United States
Paul Dent
Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, United States
DOI
https://doi.org/10.3389/fonc.2021.677725
Journal volume & issue
Vol. 11
Abstract
Read online
No abstracts available.
Keywords
autophagy
GZ17-6.02
sarcoma
doxorubicin
CD95
death receptor
WeChat QR code
Close